Medical Care
Global NIPT(NIPS) Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2031
- Nov 18, 25
- ID: 574044
- Pages: 142
- Figures: 137
- Views: 10
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global NIPT(NIPS) Testing Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Illumina
Natera
Roche
Labcorp
Quest Diagnostics
BGI Genomics
Eurofins Scientific
Myriad Genetics
Berry Genomics
Fulgent Genetics
GenPath Diagnostics
Daan Gene
CapitalBio
Segment by Type
Below 20 Test Items
20-40 Test Items
Above 40 Test Items
Segment by Application
Advanced Maternal Age
Non Advanced Maternal Age
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the NIPT(NIPS) Testing Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global NIPT(NIPS) Testing Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Illumina
Natera
Roche
Labcorp
Quest Diagnostics
BGI Genomics
Eurofins Scientific
Myriad Genetics
Berry Genomics
Fulgent Genetics
GenPath Diagnostics
Daan Gene
CapitalBio
Segment by Type
Below 20 Test Items
20-40 Test Items
Above 40 Test Items
Segment by Application
Advanced Maternal Age
Non Advanced Maternal Age
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the NIPT(NIPS) Testing Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to NIPT(NIPS) Testing Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global NIPT(NIPS) Testing Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Below 20 Test Items
1.2.3 20-40 Test Items
1.2.4 Above 40 Test Items
1.3 Market Segmentation by Application
1.3.1 Global NIPT(NIPS) Testing Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Advanced Maternal Age
1.3.3 Non Advanced Maternal Age
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global NIPT(NIPS) Testing Service Revenue Estimates and Forecasts 2020-2031
2.2 Global NIPT(NIPS) Testing Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global NIPT(NIPS) Testing Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global NIPT(NIPS) Testing Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Below 20 Test Items Market Size by Players
3.3.2 20-40 Test Items Market Size by Players
3.3.3 Above 40 Test Items Market Size by Players
3.4 Global NIPT(NIPS) Testing Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global NIPT(NIPS) Testing Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global NIPT(NIPS) Testing Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America NIPT(NIPS) Testing Service Market Size by Type (2020-2031)
6.4 North America NIPT(NIPS) Testing Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America NIPT(NIPS) Testing Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe NIPT(NIPS) Testing Service Market Size by Type (2020-2031)
7.4 Europe NIPT(NIPS) Testing Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe NIPT(NIPS) Testing Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific NIPT(NIPS) Testing Service Market Size by Type (2020-2031)
8.4 Asia-Pacific NIPT(NIPS) Testing Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific NIPT(NIPS) Testing Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America NIPT(NIPS) Testing Service Market Size by Type (2020-2031)
9.4 Central and South America NIPT(NIPS) Testing Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America NIPT(NIPS) Testing Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa NIPT(NIPS) Testing Service Market Size by Type (2020-2031)
10.4 Middle East and Africa NIPT(NIPS) Testing Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa NIPT(NIPS) Testing Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Illumina
11.1.1 Illumina Corporation Information
11.1.2 Illumina Business Overview
11.1.3 Illumina NIPT(NIPS) Testing Service Product Features and Attributes
11.1.4 Illumina NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.1.5 Illumina NIPT(NIPS) Testing Service Revenue by Product in 2024
11.1.6 Illumina NIPT(NIPS) Testing Service Revenue by Application in 2024
11.1.7 Illumina NIPT(NIPS) Testing Service Revenue by Geographic Area in 2024
11.1.8 Illumina NIPT(NIPS) Testing Service SWOT Analysis
11.1.9 Illumina Recent Developments
11.2 Natera
11.2.1 Natera Corporation Information
11.2.2 Natera Business Overview
11.2.3 Natera NIPT(NIPS) Testing Service Product Features and Attributes
11.2.4 Natera NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.2.5 Natera NIPT(NIPS) Testing Service Revenue by Product in 2024
11.2.6 Natera NIPT(NIPS) Testing Service Revenue by Application in 2024
11.2.7 Natera NIPT(NIPS) Testing Service Revenue by Geographic Area in 2024
11.2.8 Natera NIPT(NIPS) Testing Service SWOT Analysis
11.2.9 Natera Recent Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Business Overview
11.3.3 Roche NIPT(NIPS) Testing Service Product Features and Attributes
11.3.4 Roche NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.3.5 Roche NIPT(NIPS) Testing Service Revenue by Product in 2024
11.3.6 Roche NIPT(NIPS) Testing Service Revenue by Application in 2024
11.3.7 Roche NIPT(NIPS) Testing Service Revenue by Geographic Area in 2024
11.3.8 Roche NIPT(NIPS) Testing Service SWOT Analysis
11.3.9 Roche Recent Developments
11.4 Labcorp
11.4.1 Labcorp Corporation Information
11.4.2 Labcorp Business Overview
11.4.3 Labcorp NIPT(NIPS) Testing Service Product Features and Attributes
11.4.4 Labcorp NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.4.5 Labcorp NIPT(NIPS) Testing Service Revenue by Product in 2024
11.4.6 Labcorp NIPT(NIPS) Testing Service Revenue by Application in 2024
11.4.7 Labcorp NIPT(NIPS) Testing Service Revenue by Geographic Area in 2024
11.4.8 Labcorp NIPT(NIPS) Testing Service SWOT Analysis
11.4.9 Labcorp Recent Developments
11.5 Quest Diagnostics
11.5.1 Quest Diagnostics Corporation Information
11.5.2 Quest Diagnostics Business Overview
11.5.3 Quest Diagnostics NIPT(NIPS) Testing Service Product Features and Attributes
11.5.4 Quest Diagnostics NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.5.5 Quest Diagnostics NIPT(NIPS) Testing Service Revenue by Product in 2024
11.5.6 Quest Diagnostics NIPT(NIPS) Testing Service Revenue by Application in 2024
11.5.7 Quest Diagnostics NIPT(NIPS) Testing Service Revenue by Geographic Area in 2024
11.5.8 Quest Diagnostics NIPT(NIPS) Testing Service SWOT Analysis
11.5.9 Quest Diagnostics Recent Developments
11.6 BGI Genomics
11.6.1 BGI Genomics Corporation Information
11.6.2 BGI Genomics Business Overview
11.6.3 BGI Genomics NIPT(NIPS) Testing Service Product Features and Attributes
11.6.4 BGI Genomics NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.6.5 BGI Genomics Recent Developments
11.7 Eurofins Scientific
11.7.1 Eurofins Scientific Corporation Information
11.7.2 Eurofins Scientific Business Overview
11.7.3 Eurofins Scientific NIPT(NIPS) Testing Service Product Features and Attributes
11.7.4 Eurofins Scientific NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.7.5 Eurofins Scientific Recent Developments
11.8 Myriad Genetics
11.8.1 Myriad Genetics Corporation Information
11.8.2 Myriad Genetics Business Overview
11.8.3 Myriad Genetics NIPT(NIPS) Testing Service Product Features and Attributes
11.8.4 Myriad Genetics NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.8.5 Myriad Genetics Recent Developments
11.9 Berry Genomics
11.9.1 Berry Genomics Corporation Information
11.9.2 Berry Genomics Business Overview
11.9.3 Berry Genomics NIPT(NIPS) Testing Service Product Features and Attributes
11.9.4 Berry Genomics NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.9.5 Berry Genomics Recent Developments
11.10 Fulgent Genetics
11.10.1 Fulgent Genetics Corporation Information
11.10.2 Fulgent Genetics Business Overview
11.10.3 Fulgent Genetics NIPT(NIPS) Testing Service Product Features and Attributes
11.10.4 Fulgent Genetics NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 GenPath Diagnostics
11.11.1 GenPath Diagnostics Corporation Information
11.11.2 GenPath Diagnostics Business Overview
11.11.3 GenPath Diagnostics NIPT(NIPS) Testing Service Product Features and Attributes
11.11.4 GenPath Diagnostics NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.11.5 GenPath Diagnostics Recent Developments
11.12 Daan Gene
11.12.1 Daan Gene Corporation Information
11.12.2 Daan Gene Business Overview
11.12.3 Daan Gene NIPT(NIPS) Testing Service Product Features and Attributes
11.12.4 Daan Gene NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.12.5 Daan Gene Recent Developments
11.13 CapitalBio
11.13.1 CapitalBio Corporation Information
11.13.2 CapitalBio Business Overview
11.13.3 CapitalBio NIPT(NIPS) Testing Service Product Features and Attributes
11.13.4 CapitalBio NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.13.5 CapitalBio Recent Developments
12 NIPT(NIPS) Testing ServiceIndustry Chain Analysis
12.1 NIPT(NIPS) Testing Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 NIPT(NIPS) Testing Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global NIPT(NIPS) Testing Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to NIPT(NIPS) Testing Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global NIPT(NIPS) Testing Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Below 20 Test Items
1.2.3 20-40 Test Items
1.2.4 Above 40 Test Items
1.3 Market Segmentation by Application
1.3.1 Global NIPT(NIPS) Testing Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Advanced Maternal Age
1.3.3 Non Advanced Maternal Age
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global NIPT(NIPS) Testing Service Revenue Estimates and Forecasts 2020-2031
2.2 Global NIPT(NIPS) Testing Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global NIPT(NIPS) Testing Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global NIPT(NIPS) Testing Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Below 20 Test Items Market Size by Players
3.3.2 20-40 Test Items Market Size by Players
3.3.3 Above 40 Test Items Market Size by Players
3.4 Global NIPT(NIPS) Testing Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global NIPT(NIPS) Testing Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global NIPT(NIPS) Testing Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America NIPT(NIPS) Testing Service Market Size by Type (2020-2031)
6.4 North America NIPT(NIPS) Testing Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America NIPT(NIPS) Testing Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe NIPT(NIPS) Testing Service Market Size by Type (2020-2031)
7.4 Europe NIPT(NIPS) Testing Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe NIPT(NIPS) Testing Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific NIPT(NIPS) Testing Service Market Size by Type (2020-2031)
8.4 Asia-Pacific NIPT(NIPS) Testing Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific NIPT(NIPS) Testing Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America NIPT(NIPS) Testing Service Market Size by Type (2020-2031)
9.4 Central and South America NIPT(NIPS) Testing Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America NIPT(NIPS) Testing Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa NIPT(NIPS) Testing Service Market Size by Type (2020-2031)
10.4 Middle East and Africa NIPT(NIPS) Testing Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa NIPT(NIPS) Testing Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Illumina
11.1.1 Illumina Corporation Information
11.1.2 Illumina Business Overview
11.1.3 Illumina NIPT(NIPS) Testing Service Product Features and Attributes
11.1.4 Illumina NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.1.5 Illumina NIPT(NIPS) Testing Service Revenue by Product in 2024
11.1.6 Illumina NIPT(NIPS) Testing Service Revenue by Application in 2024
11.1.7 Illumina NIPT(NIPS) Testing Service Revenue by Geographic Area in 2024
11.1.8 Illumina NIPT(NIPS) Testing Service SWOT Analysis
11.1.9 Illumina Recent Developments
11.2 Natera
11.2.1 Natera Corporation Information
11.2.2 Natera Business Overview
11.2.3 Natera NIPT(NIPS) Testing Service Product Features and Attributes
11.2.4 Natera NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.2.5 Natera NIPT(NIPS) Testing Service Revenue by Product in 2024
11.2.6 Natera NIPT(NIPS) Testing Service Revenue by Application in 2024
11.2.7 Natera NIPT(NIPS) Testing Service Revenue by Geographic Area in 2024
11.2.8 Natera NIPT(NIPS) Testing Service SWOT Analysis
11.2.9 Natera Recent Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Business Overview
11.3.3 Roche NIPT(NIPS) Testing Service Product Features and Attributes
11.3.4 Roche NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.3.5 Roche NIPT(NIPS) Testing Service Revenue by Product in 2024
11.3.6 Roche NIPT(NIPS) Testing Service Revenue by Application in 2024
11.3.7 Roche NIPT(NIPS) Testing Service Revenue by Geographic Area in 2024
11.3.8 Roche NIPT(NIPS) Testing Service SWOT Analysis
11.3.9 Roche Recent Developments
11.4 Labcorp
11.4.1 Labcorp Corporation Information
11.4.2 Labcorp Business Overview
11.4.3 Labcorp NIPT(NIPS) Testing Service Product Features and Attributes
11.4.4 Labcorp NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.4.5 Labcorp NIPT(NIPS) Testing Service Revenue by Product in 2024
11.4.6 Labcorp NIPT(NIPS) Testing Service Revenue by Application in 2024
11.4.7 Labcorp NIPT(NIPS) Testing Service Revenue by Geographic Area in 2024
11.4.8 Labcorp NIPT(NIPS) Testing Service SWOT Analysis
11.4.9 Labcorp Recent Developments
11.5 Quest Diagnostics
11.5.1 Quest Diagnostics Corporation Information
11.5.2 Quest Diagnostics Business Overview
11.5.3 Quest Diagnostics NIPT(NIPS) Testing Service Product Features and Attributes
11.5.4 Quest Diagnostics NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.5.5 Quest Diagnostics NIPT(NIPS) Testing Service Revenue by Product in 2024
11.5.6 Quest Diagnostics NIPT(NIPS) Testing Service Revenue by Application in 2024
11.5.7 Quest Diagnostics NIPT(NIPS) Testing Service Revenue by Geographic Area in 2024
11.5.8 Quest Diagnostics NIPT(NIPS) Testing Service SWOT Analysis
11.5.9 Quest Diagnostics Recent Developments
11.6 BGI Genomics
11.6.1 BGI Genomics Corporation Information
11.6.2 BGI Genomics Business Overview
11.6.3 BGI Genomics NIPT(NIPS) Testing Service Product Features and Attributes
11.6.4 BGI Genomics NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.6.5 BGI Genomics Recent Developments
11.7 Eurofins Scientific
11.7.1 Eurofins Scientific Corporation Information
11.7.2 Eurofins Scientific Business Overview
11.7.3 Eurofins Scientific NIPT(NIPS) Testing Service Product Features and Attributes
11.7.4 Eurofins Scientific NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.7.5 Eurofins Scientific Recent Developments
11.8 Myriad Genetics
11.8.1 Myriad Genetics Corporation Information
11.8.2 Myriad Genetics Business Overview
11.8.3 Myriad Genetics NIPT(NIPS) Testing Service Product Features and Attributes
11.8.4 Myriad Genetics NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.8.5 Myriad Genetics Recent Developments
11.9 Berry Genomics
11.9.1 Berry Genomics Corporation Information
11.9.2 Berry Genomics Business Overview
11.9.3 Berry Genomics NIPT(NIPS) Testing Service Product Features and Attributes
11.9.4 Berry Genomics NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.9.5 Berry Genomics Recent Developments
11.10 Fulgent Genetics
11.10.1 Fulgent Genetics Corporation Information
11.10.2 Fulgent Genetics Business Overview
11.10.3 Fulgent Genetics NIPT(NIPS) Testing Service Product Features and Attributes
11.10.4 Fulgent Genetics NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 GenPath Diagnostics
11.11.1 GenPath Diagnostics Corporation Information
11.11.2 GenPath Diagnostics Business Overview
11.11.3 GenPath Diagnostics NIPT(NIPS) Testing Service Product Features and Attributes
11.11.4 GenPath Diagnostics NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.11.5 GenPath Diagnostics Recent Developments
11.12 Daan Gene
11.12.1 Daan Gene Corporation Information
11.12.2 Daan Gene Business Overview
11.12.3 Daan Gene NIPT(NIPS) Testing Service Product Features and Attributes
11.12.4 Daan Gene NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.12.5 Daan Gene Recent Developments
11.13 CapitalBio
11.13.1 CapitalBio Corporation Information
11.13.2 CapitalBio Business Overview
11.13.3 CapitalBio NIPT(NIPS) Testing Service Product Features and Attributes
11.13.4 CapitalBio NIPT(NIPS) Testing Service Revenue and Gross Margin (2020-2025)
11.13.5 CapitalBio Recent Developments
12 NIPT(NIPS) Testing ServiceIndustry Chain Analysis
12.1 NIPT(NIPS) Testing Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 NIPT(NIPS) Testing Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global NIPT(NIPS) Testing Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global NIPT(NIPS) Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global NIPT(NIPS) Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global NIPT(NIPS) Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global NIPT(NIPS) Testing Service Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global NIPT(NIPS) Testing Service Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global NIPT(NIPS) Testing Service Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global NIPT(NIPS) Testing Service Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global NIPT(NIPS) Testing Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NIPT(NIPS) Testing Service as of 2024)
Table 11. Global NIPT(NIPS) Testing Service Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global NIPT(NIPS) Testing Service Companies Headquarters
Table 13. Global NIPT(NIPS) Testing Service Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global NIPT(NIPS) Testing Service Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global NIPT(NIPS) Testing Service Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global NIPT(NIPS) Testing Service Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global NIPT(NIPS) Testing Service Revenue by Application (2026-2031) & (US$ Million)
Table 21. NIPT(NIPS) Testing Service High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America NIPT(NIPS) Testing Service Growth Accelerators and Market Barriers
Table 25. North America NIPT(NIPS) Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe NIPT(NIPS) Testing Service Growth Accelerators and Market Barriers
Table 27. Europe NIPT(NIPS) Testing Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific NIPT(NIPS) Testing Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific NIPT(NIPS) Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America NIPT(NIPS) Testing Service Investment Opportunities and Key Challenges
Table 31. Central and South America NIPT(NIPS) Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa NIPT(NIPS) Testing Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa NIPT(NIPS) Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Illumina Corporation Information
Table 35. Illumina Description and Major Businesses
Table 36. Illumina Product Features and Attributes
Table 37. Illumina Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Illumina Revenue Proportion by Product in 2024
Table 39. Illumina Revenue Proportion by Application in 2024
Table 40. Illumina Revenue Proportion by Geographic Area in 2024
Table 41. Illumina NIPT(NIPS) Testing Service SWOT Analysis
Table 42. Illumina Recent Developments
Table 43. Natera Corporation Information
Table 44. Natera Description and Major Businesses
Table 45. Natera Product Features and Attributes
Table 46. Natera Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Natera Revenue Proportion by Product in 2024
Table 48. Natera Revenue Proportion by Application in 2024
Table 49. Natera Revenue Proportion by Geographic Area in 2024
Table 50. Natera NIPT(NIPS) Testing Service SWOT Analysis
Table 51. Natera Recent Developments
Table 52. Roche Corporation Information
Table 53. Roche Description and Major Businesses
Table 54. Roche Product Features and Attributes
Table 55. Roche Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Roche Revenue Proportion by Product in 2024
Table 57. Roche Revenue Proportion by Application in 2024
Table 58. Roche Revenue Proportion by Geographic Area in 2024
Table 59. Roche NIPT(NIPS) Testing Service SWOT Analysis
Table 60. Roche Recent Developments
Table 61. Labcorp Corporation Information
Table 62. Labcorp Description and Major Businesses
Table 63. Labcorp Product Features and Attributes
Table 64. Labcorp Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Labcorp Revenue Proportion by Product in 2024
Table 66. Labcorp Revenue Proportion by Application in 2024
Table 67. Labcorp Revenue Proportion by Geographic Area in 2024
Table 68. Labcorp NIPT(NIPS) Testing Service SWOT Analysis
Table 69. Labcorp Recent Developments
Table 70. Quest Diagnostics Corporation Information
Table 71. Quest Diagnostics Description and Major Businesses
Table 72. Quest Diagnostics Product Features and Attributes
Table 73. Quest Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Quest Diagnostics Revenue Proportion by Product in 2024
Table 75. Quest Diagnostics Revenue Proportion by Application in 2024
Table 76. Quest Diagnostics Revenue Proportion by Geographic Area in 2024
Table 77. Quest Diagnostics NIPT(NIPS) Testing Service SWOT Analysis
Table 78. Quest Diagnostics Recent Developments
Table 79. BGI Genomics Corporation Information
Table 80. BGI Genomics Description and Major Businesses
Table 81. BGI Genomics Product Features and Attributes
Table 82. BGI Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. BGI Genomics Recent Developments
Table 84. Eurofins Scientific Corporation Information
Table 85. Eurofins Scientific Description and Major Businesses
Table 86. Eurofins Scientific Product Features and Attributes
Table 87. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Eurofins Scientific Recent Developments
Table 89. Myriad Genetics Corporation Information
Table 90. Myriad Genetics Description and Major Businesses
Table 91. Myriad Genetics Product Features and Attributes
Table 92. Myriad Genetics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Myriad Genetics Recent Developments
Table 94. Berry Genomics Corporation Information
Table 95. Berry Genomics Description and Major Businesses
Table 96. Berry Genomics Product Features and Attributes
Table 97. Berry Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Berry Genomics Recent Developments
Table 99. Fulgent Genetics Corporation Information
Table 100. Fulgent Genetics Description and Major Businesses
Table 101. Fulgent Genetics Product Features and Attributes
Table 102. Fulgent Genetics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Fulgent Genetics Recent Developments
Table 104. GenPath Diagnostics Corporation Information
Table 105. GenPath Diagnostics Description and Major Businesses
Table 106. GenPath Diagnostics Product Features and Attributes
Table 107. GenPath Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. GenPath Diagnostics Recent Developments
Table 109. Daan Gene Corporation Information
Table 110. Daan Gene Description and Major Businesses
Table 111. Daan Gene Product Features and Attributes
Table 112. Daan Gene Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Daan Gene Recent Developments
Table 114. CapitalBio Corporation Information
Table 115. CapitalBio Description and Major Businesses
Table 116. CapitalBio Product Features and Attributes
Table 117. CapitalBio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. CapitalBio Recent Developments
Table 119. Raw Materials Key Suppliers
Table 120. Distributors List
Table 121. Market Trends and Market Evolution
Table 122. Market Drivers and Opportunities
Table 123. Market Challenges, Risks, and Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. NIPT(NIPS) Testing Service Product Picture
Figure 2. Global NIPT(NIPS) Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Below 20 Test Items Product Picture
Figure 4. 20-40 Test Items Product Picture
Figure 5. Above 40 Test Items Product Picture
Figure 6. Global NIPT(NIPS) Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Advanced Maternal Age
Figure 8. Non Advanced Maternal Age
Figure 9. NIPT(NIPS) Testing Service Report Years Considered
Figure 10. Global NIPT(NIPS) Testing Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 12. Global NIPT(NIPS) Testing Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global NIPT(NIPS) Testing Service Revenue Market Share by Region (2020-2031)
Figure 14. Global NIPT(NIPS) Testing Service Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. Below 20 Test Items Revenue Market Share by Player in 2024
Figure 17. 20-40 Test Items Revenue Market Share by Player in 2024
Figure 18. Above 40 Test Items Revenue Market Share by Player in 2024
Figure 19. Global NIPT(NIPS) Testing Service Revenue Market Share by Type (2020-2031)
Figure 20. Global NIPT(NIPS) Testing Service Revenue Market Share by Application (2020-2031)
Figure 21. North America NIPT(NIPS) Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 22. North America Top 5 Players NIPT(NIPS) Testing Service Revenue (US$ Million) in 2024
Figure 23. North America NIPT(NIPS) Testing Service Revenue (US$ Million) by Type (2020 - 2031)
Figure 24. North America NIPT(NIPS) Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 25. US NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 26. Canada NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 27. Mexico NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 28. Europe NIPT(NIPS) Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 29. Europe Top 5 Players NIPT(NIPS) Testing Service Revenue (US$ Million) in 2024
Figure 30. Europe NIPT(NIPS) Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 31. Europe NIPT(NIPS) Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 32. Germany NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 33. France NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 34. U.K. NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 35. Italy NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 36. Russia NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific NIPT(NIPS) Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Top 8 Players NIPT(NIPS) Testing Service Revenue (US$ Million) in 2024
Figure 39. Asia-Pacific NIPT(NIPS) Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 40. Asia-Pacific NIPT(NIPS) Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 41. Indonesia NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 42. Japan NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 43. South Korea NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 44. Australia NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 45. India NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 46. Indonesia NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 47. Vietnam NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 48. Malaysia NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 49. Philippines NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 50. Singapore NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 51. Central and South America NIPT(NIPS) Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Central and South America Top 5 Players NIPT(NIPS) Testing Service Revenue (US$ Million) in 2024
Figure 53. Central and South America NIPT(NIPS) Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 54. Central and South America NIPT(NIPS) Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 55. Brazil NIPT(NIPS) Testing Service Revenue (2020-2025) & (US$ Million)
Figure 56. Argentina NIPT(NIPS) Testing Service Revenue (2020-2025) & (US$ Million)
Figure 57. Middle East and Africa NIPT(NIPS) Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 58. Middle East and Africa Top 5 Players NIPT(NIPS) Testing Service Revenue (US$ Million) in 2024
Figure 59. South America NIPT(NIPS) Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 60. Middle East and Africa NIPT(NIPS) Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 61. GCC Countries NIPT(NIPS) Testing Service Revenue (2020-2025) & (US$ Million)
Figure 62. Israel NIPT(NIPS) Testing Service Revenue (2020-2025) & (US$ Million)
Figure 63. Egypt NIPT(NIPS) Testing Service Revenue (2020-2025) & (US$ Million)
Figure 64. South Africa NIPT(NIPS) Testing Service Revenue (2020-2025) & (US$ Million)
Figure 65. NIPT(NIPS) Testing Service Industry Chain Mapping
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Table 1. Global NIPT(NIPS) Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global NIPT(NIPS) Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global NIPT(NIPS) Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global NIPT(NIPS) Testing Service Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global NIPT(NIPS) Testing Service Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global NIPT(NIPS) Testing Service Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global NIPT(NIPS) Testing Service Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global NIPT(NIPS) Testing Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NIPT(NIPS) Testing Service as of 2024)
Table 11. Global NIPT(NIPS) Testing Service Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global NIPT(NIPS) Testing Service Companies Headquarters
Table 13. Global NIPT(NIPS) Testing Service Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global NIPT(NIPS) Testing Service Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global NIPT(NIPS) Testing Service Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global NIPT(NIPS) Testing Service Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global NIPT(NIPS) Testing Service Revenue by Application (2026-2031) & (US$ Million)
Table 21. NIPT(NIPS) Testing Service High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America NIPT(NIPS) Testing Service Growth Accelerators and Market Barriers
Table 25. North America NIPT(NIPS) Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe NIPT(NIPS) Testing Service Growth Accelerators and Market Barriers
Table 27. Europe NIPT(NIPS) Testing Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific NIPT(NIPS) Testing Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific NIPT(NIPS) Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America NIPT(NIPS) Testing Service Investment Opportunities and Key Challenges
Table 31. Central and South America NIPT(NIPS) Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa NIPT(NIPS) Testing Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa NIPT(NIPS) Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Illumina Corporation Information
Table 35. Illumina Description and Major Businesses
Table 36. Illumina Product Features and Attributes
Table 37. Illumina Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Illumina Revenue Proportion by Product in 2024
Table 39. Illumina Revenue Proportion by Application in 2024
Table 40. Illumina Revenue Proportion by Geographic Area in 2024
Table 41. Illumina NIPT(NIPS) Testing Service SWOT Analysis
Table 42. Illumina Recent Developments
Table 43. Natera Corporation Information
Table 44. Natera Description and Major Businesses
Table 45. Natera Product Features and Attributes
Table 46. Natera Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Natera Revenue Proportion by Product in 2024
Table 48. Natera Revenue Proportion by Application in 2024
Table 49. Natera Revenue Proportion by Geographic Area in 2024
Table 50. Natera NIPT(NIPS) Testing Service SWOT Analysis
Table 51. Natera Recent Developments
Table 52. Roche Corporation Information
Table 53. Roche Description and Major Businesses
Table 54. Roche Product Features and Attributes
Table 55. Roche Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Roche Revenue Proportion by Product in 2024
Table 57. Roche Revenue Proportion by Application in 2024
Table 58. Roche Revenue Proportion by Geographic Area in 2024
Table 59. Roche NIPT(NIPS) Testing Service SWOT Analysis
Table 60. Roche Recent Developments
Table 61. Labcorp Corporation Information
Table 62. Labcorp Description and Major Businesses
Table 63. Labcorp Product Features and Attributes
Table 64. Labcorp Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Labcorp Revenue Proportion by Product in 2024
Table 66. Labcorp Revenue Proportion by Application in 2024
Table 67. Labcorp Revenue Proportion by Geographic Area in 2024
Table 68. Labcorp NIPT(NIPS) Testing Service SWOT Analysis
Table 69. Labcorp Recent Developments
Table 70. Quest Diagnostics Corporation Information
Table 71. Quest Diagnostics Description and Major Businesses
Table 72. Quest Diagnostics Product Features and Attributes
Table 73. Quest Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Quest Diagnostics Revenue Proportion by Product in 2024
Table 75. Quest Diagnostics Revenue Proportion by Application in 2024
Table 76. Quest Diagnostics Revenue Proportion by Geographic Area in 2024
Table 77. Quest Diagnostics NIPT(NIPS) Testing Service SWOT Analysis
Table 78. Quest Diagnostics Recent Developments
Table 79. BGI Genomics Corporation Information
Table 80. BGI Genomics Description and Major Businesses
Table 81. BGI Genomics Product Features and Attributes
Table 82. BGI Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. BGI Genomics Recent Developments
Table 84. Eurofins Scientific Corporation Information
Table 85. Eurofins Scientific Description and Major Businesses
Table 86. Eurofins Scientific Product Features and Attributes
Table 87. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Eurofins Scientific Recent Developments
Table 89. Myriad Genetics Corporation Information
Table 90. Myriad Genetics Description and Major Businesses
Table 91. Myriad Genetics Product Features and Attributes
Table 92. Myriad Genetics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Myriad Genetics Recent Developments
Table 94. Berry Genomics Corporation Information
Table 95. Berry Genomics Description and Major Businesses
Table 96. Berry Genomics Product Features and Attributes
Table 97. Berry Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Berry Genomics Recent Developments
Table 99. Fulgent Genetics Corporation Information
Table 100. Fulgent Genetics Description and Major Businesses
Table 101. Fulgent Genetics Product Features and Attributes
Table 102. Fulgent Genetics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Fulgent Genetics Recent Developments
Table 104. GenPath Diagnostics Corporation Information
Table 105. GenPath Diagnostics Description and Major Businesses
Table 106. GenPath Diagnostics Product Features and Attributes
Table 107. GenPath Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. GenPath Diagnostics Recent Developments
Table 109. Daan Gene Corporation Information
Table 110. Daan Gene Description and Major Businesses
Table 111. Daan Gene Product Features and Attributes
Table 112. Daan Gene Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Daan Gene Recent Developments
Table 114. CapitalBio Corporation Information
Table 115. CapitalBio Description and Major Businesses
Table 116. CapitalBio Product Features and Attributes
Table 117. CapitalBio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. CapitalBio Recent Developments
Table 119. Raw Materials Key Suppliers
Table 120. Distributors List
Table 121. Market Trends and Market Evolution
Table 122. Market Drivers and Opportunities
Table 123. Market Challenges, Risks, and Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. NIPT(NIPS) Testing Service Product Picture
Figure 2. Global NIPT(NIPS) Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Below 20 Test Items Product Picture
Figure 4. 20-40 Test Items Product Picture
Figure 5. Above 40 Test Items Product Picture
Figure 6. Global NIPT(NIPS) Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Advanced Maternal Age
Figure 8. Non Advanced Maternal Age
Figure 9. NIPT(NIPS) Testing Service Report Years Considered
Figure 10. Global NIPT(NIPS) Testing Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 12. Global NIPT(NIPS) Testing Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global NIPT(NIPS) Testing Service Revenue Market Share by Region (2020-2031)
Figure 14. Global NIPT(NIPS) Testing Service Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. Below 20 Test Items Revenue Market Share by Player in 2024
Figure 17. 20-40 Test Items Revenue Market Share by Player in 2024
Figure 18. Above 40 Test Items Revenue Market Share by Player in 2024
Figure 19. Global NIPT(NIPS) Testing Service Revenue Market Share by Type (2020-2031)
Figure 20. Global NIPT(NIPS) Testing Service Revenue Market Share by Application (2020-2031)
Figure 21. North America NIPT(NIPS) Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 22. North America Top 5 Players NIPT(NIPS) Testing Service Revenue (US$ Million) in 2024
Figure 23. North America NIPT(NIPS) Testing Service Revenue (US$ Million) by Type (2020 - 2031)
Figure 24. North America NIPT(NIPS) Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 25. US NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 26. Canada NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 27. Mexico NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 28. Europe NIPT(NIPS) Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 29. Europe Top 5 Players NIPT(NIPS) Testing Service Revenue (US$ Million) in 2024
Figure 30. Europe NIPT(NIPS) Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 31. Europe NIPT(NIPS) Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 32. Germany NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 33. France NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 34. U.K. NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 35. Italy NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 36. Russia NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific NIPT(NIPS) Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Top 8 Players NIPT(NIPS) Testing Service Revenue (US$ Million) in 2024
Figure 39. Asia-Pacific NIPT(NIPS) Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 40. Asia-Pacific NIPT(NIPS) Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 41. Indonesia NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 42. Japan NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 43. South Korea NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 44. Australia NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 45. India NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 46. Indonesia NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 47. Vietnam NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 48. Malaysia NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 49. Philippines NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 50. Singapore NIPT(NIPS) Testing Service Revenue (2020-2031) & (US$ Million)
Figure 51. Central and South America NIPT(NIPS) Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Central and South America Top 5 Players NIPT(NIPS) Testing Service Revenue (US$ Million) in 2024
Figure 53. Central and South America NIPT(NIPS) Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 54. Central and South America NIPT(NIPS) Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 55. Brazil NIPT(NIPS) Testing Service Revenue (2020-2025) & (US$ Million)
Figure 56. Argentina NIPT(NIPS) Testing Service Revenue (2020-2025) & (US$ Million)
Figure 57. Middle East and Africa NIPT(NIPS) Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 58. Middle East and Africa Top 5 Players NIPT(NIPS) Testing Service Revenue (US$ Million) in 2024
Figure 59. South America NIPT(NIPS) Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 60. Middle East and Africa NIPT(NIPS) Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 61. GCC Countries NIPT(NIPS) Testing Service Revenue (2020-2025) & (US$ Million)
Figure 62. Israel NIPT(NIPS) Testing Service Revenue (2020-2025) & (US$ Million)
Figure 63. Egypt NIPT(NIPS) Testing Service Revenue (2020-2025) & (US$ Million)
Figure 64. South Africa NIPT(NIPS) Testing Service Revenue (2020-2025) & (US$ Million)
Figure 65. NIPT(NIPS) Testing Service Industry Chain Mapping
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232